Triclosan inhibition of fatty acid synthesis and its effect on growth of Escherichia coli and Pseudomonas aeruginosa
Open Access
- 28 April 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 55 (6) , 879-882
- https://doi.org/10.1093/jac/dki123
Abstract
Objectives: To assess the effect of triclosan on fatty acid synthesis and to relate the inhibition of enoyl reductase to bacterial viability. Methods: The effect of triclosan on fatty acid synthesis in a triclosan-resistant Escherichia coli and its sensitive counterpart and in Pseudomonas aeruginosa was investigated by measuring acetate incorporation into total lipid followed by analysis of fatty acid methyl esters by gas chromatography. Concurrently, the bactericidal effect of triclosan against these bacterial strains was assessed. Results: Triclosan inhibited fatty acid biosynthesis in all the strains tested. However, for triclosan-resistant E. coli (MIC > 1000 mg/L) the concentration required to achieve inhibition was higher than that required for the susceptible counterpart. These concentrations did not significantly affect cell survival in any of the strains tested. Conclusions: This study shows that the inhibition of fatty acid biosynthesis by the bisphenol might be involved in its growth-inhibitory action and that other mechanisms are involved in its lethal effect. In addition, although microorganisms with a high triclosan MIC were still susceptible to the inhibitory effect of the bisphenol on fatty acid biosynthesis, a higher concentration of the compound was required. This suggested that triclosan bioavailability was different in these strains.Keywords
This publication has 17 references indexed in Scilit:
- Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus.Journal of Antimicrobial Chemotherapy, 2001
- Triclosan and fatty acid synthesis in Plasmodium falciparum: new weapon for an old enemy.Journal of Biosciences, 2001
- Triclosan inhibits the growth of Plasmodium falciparum and Toxoplasma gondii by inhibition of Apicomplexan Fab IInternational Journal for Parasitology, 2001
- Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparumNature Medicine, 2001
- The Enoyl-[acyl-carrier-protein] Reductases FabI and FabL fromBacillus subtilisJournal of Biological Chemistry, 2000
- A triclosan-resistant bacterial enzymeNature, 2000
- Inhibition of the Staphylococcus aureusNADPH-dependent Enoyl-Acyl Carrier Protein Reductase by Triclosan and HexachloropheneJournal of Biological Chemistry, 2000
- Molecular basis of triclosan activityNature, 1999
- Genetic Evidence that InhA of Mycobacterium smegmatis Is a Target for TriclosanAntimicrobial Agents and Chemotherapy, 1999
- Triclosan targets lipid synthesisNature, 1998